Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-10

Clinical Trial Update: Guo's Visceral Arteries Reconstruction: First in Man Study [NA]

View source ↗

Summary

First-in-man study of Lifetech's Guo's Visceral Arteries Reconstruction for thoracoabdominal and pararenal aortic aneurysms has completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm | NA | Status: COMPLETED | Results posted: 2024-07-10